The probability of BRAFV600E-positive [BRAF(+)] metastatic lesions when the primary cancer lesion was BRAF(+) and BRAFV600E-negative [BRAF(−)] metastatic lesions when the primary cancer lesion was BRAF(−) was calculated. The gene discussed is BRAF; the disease is cancer.